{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:13:06Z","timestamp":1792116786652,"version":"4.4.0"},"reference-count":195,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.idc.2009.06.002","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T05:35:33Z","timestamp":1258004133000},"page":"817-845","source":"Crossref","is-referenced-by-count":45,"title":["Pathogens Resistant to Antibacterial Agents"],"prefix":"10.1016","volume":"23","author":[{"given":"Luke F.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5073","key":"10.1016\/j.idc.2009.06.002_bib1","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.257.5073.1064","article-title":"The crisis in antibiotic resistance","volume":"257","author":"Neu","year":"1992","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/scdb.2000.0247","article-title":"Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria","volume":"12","author":"Nikaido","year":"2001","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0966-842X(97)01033-0","article-title":"Bacterial resistance to aminoglycoside antibiotics","volume":"5","author":"Davies","year":"1997","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1568005033342181","article-title":"Beta-lactamases: a survey of protein diversity","volume":"3","author":"Helfand","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"5157","key":"10.1016\/j.idc.2009.06.002_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.8153624","article-title":"Inactivation of antibiotics and the dissemination of resistance genes","volume":"264","author":"Davies","year":"1994","journal-title":"Science"},{"issue":"5157","key":"10.1016\/j.idc.2009.06.002_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.8153626","article-title":"Resistance to antibiotics mediated by target alterations","volume":"264","author":"Spratt","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.idc.2009.06.002_bib7","series-title":"Gram positive pathogens","first-page":"621","article-title":"Resistance to glycopeptides in gram-positive pathogens","author":"Fraimow","year":"2000"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2796.2002.01026.x","article-title":"Evolution and spread of antibiotic resistance","volume":"252","author":"Normark","year":"2002","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/AAC.38.7.1447","article-title":"Transfer of antibiotic resistance genes between gram-positive and gram- negative bacteria","volume":"38","author":"Courvalin","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2009.06.002_bib10","unstructured":"Moellering RC Jr. Therapeutic options for infections caused by multiply-resistant enterococci. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Orlando (FL); 4\u20137 October, 1994."},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/163.4.780","article-title":"Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states","volume":"163","author":"Murray","year":"1991","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/AAC.35.11.2180","article-title":"Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution","volume":"35","author":"Grayson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.36.5.1032","article-title":"Emergence and nosocomial transmission of ampicillin-resistant enterococci","volume":"36","author":"Boyce","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib14","first-page":"1933","article-title":"One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin","volume":"131","author":"Williamson","year":"1985","journal-title":"J Gen Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/501905","article-title":"Outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unit","volume":"22","author":"Rupp","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/clinids\/12.4.644","article-title":"High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology","volume":"12","author":"Patterson","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI109149","article-title":"Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis: an explanation for resistance to antibiotic synergism","volume":"62","author":"Krogstad","year":"1978","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0732-8893(03)00012-9","article-title":"Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997\u20132000)","volume":"46","author":"Mutnick","year":"2003","journal-title":"Diagn Microbiol\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-117-2-112","article-title":"Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers","volume":"117","author":"Livornese","year":"1992","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3201\/eid0808.010418","article-title":"Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus","volume":"8","author":"Carmeli","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.37.8.1563","article-title":"Genetics and mechanisms of glycopeptide resistance in enterococci","volume":"37","author":"Arthur","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1128\/AAC.35.4.776","article-title":"Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin","volume":"35","author":"Shlaes","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jac\/36.4.595","article-title":"vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum","volume":"36","author":"Power","year":"1995","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1128\/AAC.42.8.2055","article-title":"vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans","volume":"42","author":"Ligozzi","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/42.2.275","article-title":"Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands","volume":"42","author":"Mevius","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib27","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/AAC.38.7.1675","article-title":"Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus","volume":"38","author":"Dutka-Malen","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"10.1016\/j.idc.2009.06.002_bib28","first-page":"565","article-title":"Centers for Disease Control and Prevention (CDC) Staphylococcus aureus resistant to vancomycin\u2014United States, 2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-6968.1992.tb05089.x","article-title":"Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus","volume":"72","author":"Noble","year":"1992","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib30","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/AAC.41.9.2016","article-title":"VanD-type glycopeptide-resistant Enterococcus faecium BM4339","volume":"41","author":"Perichon","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib31","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/AAC.44.11.3224-3228.2000","article-title":"Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis","volume":"44","author":"McKessar","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib32","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/AAC.43.9.2161","article-title":"VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405","volume":"43","author":"Fines","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2009.06.002_bib33","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/AAC.45.7.2154-2156.2001","article-title":"Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci","volume":"45","author":"Prystowsky","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JCM.44.3.1153-1155.2006","article-title":"Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage","volume":"44","author":"Bonora","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2009.06.002_bib35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1086\/523276","article-title":"Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus","volume":"28","author":"Pogue","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib36","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/AAC.00774-07","article-title":"Mechanisms of resistance to daptomycin in Enterococcus faecium","volume":"52","author":"Montero","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2579","key":"10.1016\/j.idc.2009.06.002_bib37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.99.2579.452","article-title":"Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci","volume":"99","author":"Kirby","year":"1944","journal-title":"Science"},{"key":"10.1016\/j.idc.2009.06.002_bib38","series-title":"Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing","year":"2008"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/527392","article-title":"Vancomycin-resistant Staphylococcus aureus in the United States, 2002\u20132006","volume":"46","author":"Sievert","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.hrtlng.2007.12.001","article-title":"Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia due to a linezolid tolerant strain","volume":"37","author":"Cunha","year":"2008","journal-title":"Heart Lung"},{"issue":"Pt 8","key":"10.1016\/j.idc.2009.06.002_bib41","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1099\/jmm.0.2008\/000588-0","article-title":"Daptomycin non-susceptible methicillin-resistant Staphylococcus aureus USA 300 isolate","volume":"57","author":"Murthy","year":"2008","journal-title":"J Med Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbrc.2008.10.009","article-title":"Structure and specific detection of staphylococcal cassette chromosome mec type VII","volume":"377","author":"Higuchi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.idc.2009.06.002_bib43","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00629-06","article-title":"Redefining a structural variant of staphylococcal cassette chromosome mec, SCCmec type VI","volume":"50","author":"Oliveira","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib44","first-page":"531","volume":"53","author":"Zhang","year":"2009","journal-title":"Novel staphylococcal cassette chromosome mec type carrying class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib45","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.45.7.1955-1963.2001","article-title":"Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus","volume":"45","author":"Katayama","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/labinvest.3700501","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin","volume":"87","author":"Boyle-Vavra","year":"2007","journal-title":"Lab Invest"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.inf.0000073163.37519.ee","article-title":"Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children","volume":"22","author":"Martinez-Aguilar","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"5650","key":"10.1016\/j.idc.2009.06.002_bib48","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.49.1.21-25.2005","article-title":"Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine","volume":"49","author":"Reynolds","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib51","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib52","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001\u201305","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib53","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/dkn246","article-title":"Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage","volume":"62","author":"Alos","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2009.06.002_bib54","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib55","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00284-001-0023-7","article-title":"Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells","volume":"44","author":"Champney","year":"2002","journal-title":"Curr Microbiol"},{"issue":"9277","key":"10.1016\/j.idc.2009.06.002_bib58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib59","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.01098-07","article-title":"Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances","volume":"52","author":"Besier","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib60","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal\u00a0activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2009.06.002_bib61","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1086\/430352","article-title":"Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact","volume":"191","author":"Silverman","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","article-title":"Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin","volume":"44","author":"Skiest","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib63","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.00719-07","article-title":"Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding","volume":"52","author":"Jones","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib65","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib66","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jac\/48.6.939","article-title":"Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin\/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides","volume":"48","author":"Schmitz","year":"2001","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1469-0691.2008.01993.x","article-title":"A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp","volume":"14","author":"Drago","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib68","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/AAC.39.9.2027","article-title":"Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB","volume":"39","author":"Allignet","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/JCM.27.3.405-410.1989","article-title":"Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci","volume":"27","author":"Markiewicz","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib70","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.46.5.1273-1280.2002","volume":"46","author":"Nagai","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","article-title":"Penicillin-binding proteins and beta-lactam resistance","volume":"32","author":"Zapun","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"16","key":"10.1016\/j.idc.2009.06.002_bib72","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1074\/jbc.M313492200","article-title":"A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics","volume":"279","author":"Pernot","year":"2004","journal-title":"J Biol Chem"},{"issue":"3 Suppl 1","key":"10.1016\/j.idc.2009.06.002_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3810\/pgm.2008.09.suppl52.279","article-title":"Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001\u20132005","volume":"120","author":"Sahm","year":"2008","journal-title":"Postgrad Med"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib74","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/AAC.01563-06","article-title":"Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan","volume":"51","author":"Chiu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1345\/aph.1H620","article-title":"Differences between ceftriaxone and cefotaxime: microbiological inconsistencies","volume":"42","author":"Gums","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/adc.2006.111625","article-title":"Penicillin-resistant pneumococcus and risk of treatment failure in pneumonia","volume":"93","author":"Cardoso","year":"2008","journal-title":"Arch Dis Child"},{"issue":"3 Suppl 1","key":"10.1016\/j.idc.2009.06.002_bib77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3810\/pgm.2008.09.suppl52.280","article-title":"Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective","volume":"120","author":"Sahm","year":"2008","journal-title":"Postgrad Med"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib78","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/424467","article-title":"Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact","volume":"190","author":"Rodriguez","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2009.06.002_bib79","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/382694","article-title":"Quinolone resistance among pneumococci: therapeutic and diagnostic implications","volume":"38","author":"Low","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib80","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1128\/AAC.36.8.1677","article-title":"Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France","volume":"36","author":"Sirot","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib81","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/infdis\/170.6.1622","article-title":"Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System","volume":"170","author":"Burwen","year":"1994","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib82","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ajic.2008.08.001","article-title":"National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008","volume":"36","author":"Edwards","year":"2008","journal-title":"Am J Infect Control"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib83","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0891-5520(05)70395-0","article-title":"Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams","volume":"11","author":"Jacoby","year":"1997","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jama.281.6.517","article-title":"Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes","volume":"281","author":"Wiener","year":"1999","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib85","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/clinids\/1.5.736","article-title":"Epidemiology of Klebsiella and hospital-associated infections","volume":"1","author":"Montgomerie","year":"1979","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib86","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/jhin.2002.1331","article-title":"Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan","volume":"53","author":"Lin","year":"2003","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib87","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2009.06.002_bib88","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-002-1521-1","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome","volume":"28","author":"Du","year":"2002","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib89","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0163-4453(98)94171-8","article-title":"The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital","volume":"36","author":"D'Agata","year":"1998","journal-title":"J Infect"},{"issue":"14","key":"10.1016\/j.idc.2009.06.002_bib90","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella","volume":"280","author":"Rahal","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/AAC.42.1.53","article-title":"Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases","volume":"42","author":"Pena","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib92","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3201\/eid1308.070071","article-title":"Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission","volume":"13","author":"Harris","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","article-title":"Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes","volume":"48","author":"Bonnet","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib95","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"beta-Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapenemases in gram-negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.idc.2009.06.002_bib97","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1086\/592412","article-title":"Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib98","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.40.2.342","article-title":"In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins","volume":"40","author":"Martinez-Martinez","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib99","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/159.5.1005","article-title":"In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase","volume":"159","author":"Pangon","year":"1989","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.48.5.1520-1525.2004","article-title":"Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States","volume":"48","author":"Kaye","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib101","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.38.5.1791-1796.2000","article-title":"Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center","volume":"38","author":"Coudron","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib102","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0732-8893(01)00353-4","article-title":"Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998\u201399)","volume":"42","author":"Bell","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2009.06.002_bib103","series-title":"The quinolones","author":"Andriole","year":"1998"},{"key":"10.1016\/j.idc.2009.06.002_bib104","series-title":"Douglas and Bennett's principles and practice of infectious diseases","author":"Mandell","year":"2004"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/526775","article-title":"Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline","volume":"46","author":"Anthony","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib106","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1345\/aph.1K213","article-title":"Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms","volume":"41","author":"Yang","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib107","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/clinids\/10.4.830","article-title":"Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins","volume":"10","author":"Sanders","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib108","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/JCM.01797-08","article-title":"Identification of plasmid-mediated AmpC {beta}-lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus species can potentially improve reporting of cephalosporin susceptibility testing results","volume":"47","author":"Tenover","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib109","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.jp.7211550","article-title":"Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge","volume":"26","author":"Fakioglu","year":"2006","journal-title":"J\u00a0Perinatol"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(00)81928-5","article-title":"Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria","volume":"88","author":"Jacobs","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib111","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/AAC.49.4.1404-1409.2005","article-title":"Susceptibility to antibiotics and beta-lactamase induction in murein hydrolase mutants of Escherichia coli","volume":"49","author":"Korsak","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2009.06.002_bib112","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/clinids\/24.Supplement_1.S19","article-title":"Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics","volume":"24","author":"Medeiros","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib113","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.45.9.2628-2630.2001","article-title":"Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp","volume":"45","author":"Kaye","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib114","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.48.3.716-720.2004","article-title":"Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate","volume":"48","author":"Mammeri","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib115","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2174\/138945008785747770","article-title":"Physical insights into permeation of and resistance to antibiotics in bacteria","volume":"9","author":"Ceccarelli","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00006454-200103000-00031","article-title":"Cefepime microbiologic profile and update","volume":"20","author":"Kessler","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2007.08.006","article-title":"Evaluation of antimicrobial susceptibility for beta-lactams using the Etest method against clinical isolates from 100 medical centers in Japan (2006)","volume":"60","author":"Ishii","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib118","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/17460913.2.5.501","article-title":"Carbapenemases: molecular diversity and clinical consequences","volume":"2","author":"Poirel","year":"2007","journal-title":"Future Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib119","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib120","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/512370","article-title":"Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York","volume":"44","author":"Bratu","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib121","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1086\/505598","article-title":"The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York","volume":"43","author":"Lomaestro","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib122","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/AAC.49.7.3018-3020.2005","article-title":"Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection","volume":"49","author":"Bratu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib123","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1128\/AAC.47.4.1297-1300.2003","article-title":"Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2","volume":"47","author":"Miriagou","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib124","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.01405-06","article-title":"First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase","volume":"51","author":"Villegas","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib125","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/497831","article-title":"Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia","volume":"41","author":"Peleg","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib126","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/AAC.00116-06","article-title":"Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40","volume":"50","author":"Lolans","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib127","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/dkf092","article-title":"Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics","volume":"50","author":"Danes","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/39.6.673","article-title":"Acquired carbapenemases","volume":"39","author":"Livermore","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib129","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/AAC.45.2.583-588.2001","article-title":"Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii","volume":"45","author":"Afzal-Shah","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2009.06.002_bib130","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1128\/JCM.38.9.3299-3305.2000","article-title":"Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a\u00a0carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A.\u00a0baumannii is not due solely to the presence of beta-lactamases","volume":"38","author":"Bou","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/375821","article-title":"Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City","volume":"37","author":"Quale","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2009.06.002_bib132","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/AAC.01464-06","article-title":"Global challenge of multidrug-resistant Acinetobacter baumannii","volume":"51","author":"Perez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2009.06.002_bib133","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/clinids\/24.Supplement_1.S46","article-title":"The most frequent aminoglycoside resistance mechanisms\u2013changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups","volume":"24","author":"Miller","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib134","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/39.6.757","article-title":"Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii","volume":"39","author":"Vila","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1469-0691.2003.00591.x","article-title":"The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997\u20132000","volume":"9","author":"Turner","year":"2003","journal-title":"Clin Microbiol Infect"},{"issue":"13","key":"10.1016\/j.idc.2009.06.002_bib136","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archinte.162.13.1515","article-title":"Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned","volume":"162","author":"Landman","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib137","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkm129","article-title":"Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY","volume":"60","author":"Landman","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib138","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00005792-199511000-00004","article-title":"Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality","volume":"74","author":"Seifert","year":"1995","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib139","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/49.3.471","article-title":"Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates","volume":"49","author":"Vila","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib140","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/529198","article-title":"Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options","volume":"46","author":"Maragakis","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib141","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10096-007-0279-3","article-title":"Antimicrobial therapy for Stenotrophomonas maltophilia infections","volume":"26","author":"Nicodemo","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib142","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.11.1.57","article-title":"Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia","volume":"11","author":"Denton","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib143","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jac\/46.6.879","article-title":"A TEM-2beta-lactamase\u00a0encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia","volume":"46","author":"Avison","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib144","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000238862","article-title":"Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates","volume":"37","author":"Cullmann","year":"1991","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib145","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/AAC.45.6.1879-1881.2001","article-title":"Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia","volume":"45","author":"Alonso","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib146","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/AAC.48.2.666-669.2004","article-title":"Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates","volume":"48","author":"Barbolla","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib147","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3201\/eid1304.061378","article-title":"Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes","volume":"13","author":"Toleman","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2009.06.002_bib148","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997\u20131999)","volume":"32","author":"Gales","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib149","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0732-8893(97)81808-1","article-title":"Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes","volume":"29","author":"Jones","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ppul.10216","article-title":"Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates","volume":"35","author":"Canton","year":"2003","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib151","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/dkl496","article-title":"In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia","volume":"59","author":"Insa","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1\u20132","key":"10.1016\/j.idc.2009.06.002_bib152","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0732-8893(01)00281-4","article-title":"In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations","volume":"41","author":"Krueger","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2009.06.002_bib153","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-0711-5-23","article-title":"Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem","volume":"5","author":"Al-Jasser","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib154","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QCO.0b013e32830f453a","article-title":"Antimicrobial resistance in typhoidal and nontyphoidal salmonellae","volume":"21","author":"Parry","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"22","key":"10.1016\/j.idc.2009.06.002_bib155","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib156","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/AAC.28.3.452","article-title":"Variability of IncHI1 plasmids from Salmonella typhi with special reference to Peruvian plasmids encoding resistance to trimethoprim and other antibiotics","volume":"28","author":"Taylor","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib157","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.plasmid.2004.06.006","article-title":"The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics","volume":"52","author":"Gilmour","year":"2004","journal-title":"Plasmid"},{"issue":"Pt 8","key":"10.1016\/j.idc.2009.06.002_bib158","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1099\/jmm.0.47170-0","article-title":"Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins","volume":"56","author":"Capoor","year":"2007","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib159","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/426593","article-title":"A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis","volume":"40","author":"Ko","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diagmicrobio.2005.10.016","article-title":"Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar typhi and paratyphi A isolated in Katmandu, Nepal, in 2003","volume":"54","author":"Shirakawa","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib161","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/AAC.01509-07","article-title":"Clinical response and outcome of infection with Salmonella enterica serotype typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study","volume":"52","author":"Crump","year":"2008","journal-title":"Antimicrob\u00a0Agents Chemother"},{"issue":"Pt 1","key":"10.1016\/j.idc.2009.06.002_bib162","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1099\/jmm.0.46763-0","article-title":"Emergence of nalidixic acid-resistant Salmonella enterica serovar typhi resistant to ciprofloxacin in India","volume":"56","author":"Kownhar","year":"2007","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib163","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/375602","article-title":"Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype typhi and for non-typhi salmonellae","volume":"37","author":"Crump","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib164","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jac\/dki116","article-title":"Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan","volume":"55","author":"Su","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004530.pub3","article-title":"Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)","author":"Thaver","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib166","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3201\/eid0703.017315","article-title":"Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom","volume":"7","author":"Threlfall","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2009.06.002_bib167","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1473-3099(05)70239-5","article-title":"Typhoid and paratyphoid fever in travellers","volume":"5","author":"Connor","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib168","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1017\/S0950268807009399","article-title":"Occurrence and spread of multiresistant Salmonella typhimurium DT104 in Danish animal herds investigated by the use of DNA typing and spatio-temporal analysis","volume":"136","author":"Skov","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib169","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/mdr.2008.0777","article-title":"Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000\u20132004: a report from the Enter-net International Surveillance Network","volume":"14","author":"Meakins","year":"2008","journal-title":"Microb Drug Resist"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/505397","article-title":"Plasmid-mediated quinolone resistance in non-typhi serotypes of Salmonella enterica","volume":"43","author":"Gay","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib171","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1128\/JCM.43.7.3237-3243.2005","article-title":"Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 beta-lactamases","volume":"43","author":"Li","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib172","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1086\/379668","article-title":"Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States","volume":"188","author":"Gupta","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib173","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/AAC.47.3.1165-1168.2003","article-title":"Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production","volume":"47","author":"Armand-Lefevre","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib174","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.idc.2004.10.009","article-title":"Update in traveler's diarrhea","volume":"19","author":"Shlim","year":"2005","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fm.2008.01.001","article-title":"Campylobacter and Salmonella in raw red meats in the United Kingdom: prevalence, characterization and antimicrobial resistance pattern, 2003\u20132005","volume":"25","author":"Little","year":"2008","journal-title":"Food Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib176","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0463.2007.apm_567.x","article-title":"Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea","volume":"115","author":"Ruiz","year":"2007","journal-title":"APMIS"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib177","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S0950268807008096","article-title":"Emerging fluoroquinolone and macrolide resistance of Campylobacter jejuni and Campylobacter coli isolates and their serotypes in Thai children from 1991 to 2000","volume":"135","author":"Serichantalergs","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"20","key":"10.1016\/j.idc.2009.06.002_bib178","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199905203402001","article-title":"Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992\u20131998. Investigation team","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib179","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkl210","article-title":"Macrolide resistance in Campylobacter jejuni and Campylobacter coli","volume":"58","author":"Gibreel","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.idc.2009.06.002_bib180","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/319760","article-title":"Campylobacter jejuni infections: update on emerging issues and trends","volume":"32","author":"Allos","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib181","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3201\/eid0701.010104","article-title":"Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates","volume":"7","author":"Engberg","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib182","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/jac\/dkl412","article-title":"Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure","volume":"58","author":"Yan","year":"2006","journal-title":"J\u00a0Antimicrob\u00a0Chemother"},{"issue":"46","key":"10.1016\/j.idc.2009.06.002_bib183","first-page":"1041","article-title":"Centers for Disease Control and Prevention (CDC). Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib184","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0891-5520(05)70396-2","article-title":"The impact of antimicrobial resistance on the treatment of sexually transmitted diseases","volume":"11","author":"Erbelding","year":"1997","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.idc.2009.06.002_bib185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/AAC.46.3.769-777.2002","article-title":"Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae","volume":"46","author":"Ropp","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2009.06.002_bib186","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(98)90003-4","article-title":"The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi","volume":"351","author":"Ison","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2009.06.002_bib187","series-title":"Gonococcal Isolate Surveillance Project (GISP) Annual Report","year":"2006"},{"issue":"11","key":"10.1016\/j.idc.2009.06.002_bib188","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.42.11.2799","article-title":"Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus","volume":"42","author":"Gill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2009.06.002_bib189","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.44.5.1365-1366.2000","article-title":"Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA","volume":"44","author":"Galimand","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jac\/dkg040","article-title":"Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae","volume":"51","author":"Cousin","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9372","key":"10.1016\/j.idc.2009.06.002_bib191","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0140-6736(03)13489-7","article-title":"Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002","volume":"361","author":"Fenton","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idc.2009.06.002_bib192","first-page":"274","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000","volume":"25","author":"Anonymous","year":"2001","journal-title":"Commun Dis Intell"},{"issue":"1","key":"10.1016\/j.idc.2009.06.002_bib193","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/AAC.47.1.436-439.2003","article-title":"Molecular characterization of quinolone-resistant Neisseria gonorrhoeae in Hong Kong","volume":"47","author":"Kam","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2009.06.002_bib194","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00007435-200106000-00001","article-title":"Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991\u20131999","volume":"28","author":"Trees","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.idc.2009.06.002_bib195","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.77.7.3974","article-title":"Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli","volume":"77","author":"McMurry","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.idc.2009.06.002_bib196","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003495-200464020-00004","article-title":"Efflux-mediated drug resistance in bacteria","volume":"64","author":"Li","year":"2004","journal-title":"Drugs"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552009000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552009000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T16:03:16Z","timestamp":1590249796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552009000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":195,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0891552009000476"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2009.06.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}